LA JOLLA PHARMACEUTICAL CO Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.23 | 36 | 224 | 36 | |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.30 | 36 | 191 | 5,332 | 5.3 K to 5.3 K (+0.68 %) |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.23 | 60 | 374 | 60 | |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.30 | 60 | 318 | 1,100 | 1 K to 1.1 K (+5.77 %) |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 6.23 | 230 | 1,433 | 230 | |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 5.30 | 230 | 1,219 | 13,819 | 13.6 K to 13.8 K (+1.69 %) |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 6.23 | 239 | 1,489 | 239 | |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 5.30 | 239 | 1,267 | 1,263,343 | 1.3 M to 1.3 M (+0.02 %) |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.23 | 151 | 941 | 151 | |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.30 | 151 | 800 | 77,428 | 77.3 K to 77.4 K (+0.20 %) |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 6.04 | 1,260 | 7,610 | 1,260 | |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 5.13 | 1,260 | 6,464 | 13,589 | 12.3 K to 13.6 K (+10.22 %) |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 6.04 | 246 | 1,486 | 246 | |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 5.13 | 246 | 1,262 | 1,284,446 | 1.3 M to 1.3 M (+0.02 %) |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.04 | 63 | 381 | 63 | |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.13 | 63 | 323 | 1,040 | 977 to 1 K (+6.45 %) |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.04 | 155 | 936 | 155 | |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.13 | 155 | 795 | 77,277 | 77.1 K to 77.3 K (+0.20 %) |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.04 | 37 | 223 | 37 | |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.13 | 37 | 190 | 5,296 | 5.3 K to 5.3 K (+0.70 %) |